— Know what they know.
Not Investment Advice
Also trades as: IZO.CN (CNQ) · $vol 0M

IZOZF OTC

Izotropic Corporation
1W: -8.2% 1M: -20.2% 3M: -33.8% YTD: -41.3% 1Y: -54.1% 3Y: -19.6% 5Y: -78.7%
$0.13
-0.00 (-1.92%)
 
Weekly Expected Move ±21.7%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 35 · $8.8M mcap · 63M float · 0.031% daily turnover · Short 41% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$8.8M
52W Range0.096-0.37
Volume1,300
Avg Volume19,448
Beta2.42
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORobert Louis Thast
Employees5
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2021-01-08
800 – 15355 24th Avenue
Surrey, BC V4A 2H9
CA
833 496 2677
About Izotropic Corporation

Izotropic Corporation is a medical technology company focused on bringing advanced diagnostic solutions for breast cancer to market. The firm develops and sells both a specialized breast CT imaging system and a 3D CT breast imaging platform, which are designed to facilitate earlier detection and more accurate diagnosis of breast cancer. Founded in 2016, the company's operations are headquartered in Surrey, Canada.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms